Esophageal Squamous Cell Carcinoma Stage II
2 clinical trials · Condition
◉ Watch Esophageal Squamous Cell Carcinoma Stage II
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC (NCT04973306) | Shanghai Zhongshan Hospital | 2022-03-02 |
Track Esophageal Squamous Cell Carcinoma Stage II automatically
Every clearance here is in the API, with alerts when new ones post.